Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 36 results:
Author Title Type [ Year] Filters: Keyword is Carcinoma, Hepatocellular [Clear All Filters]
Selenium and selenoprotein P in nonalcoholic fatty liver disease..
Hormones (Athens). 19(1), 61-72.
(2020).
(2019).
The role of albumin-bilirubin grade and inflammation-based index in patients with hepatocellular carcinoma treated with stereotactic body radiotherapy..
Strahlenther Onkol. 194(5), 403-413.
(2018). Immunosuppression strategies in liver transplantation patient; patients with hepatocellular carcinoma..
Immunotherapy. 9(2), 197-206.
(2017).
(2017).
(2017). Regional differences in sorafenib-treated patients with hepatocellular carcinoma: GIDEON observational study..
Liver Int. 36(8), 1196-205.
(2016).
(2016).
(2016). Molecular signalling in hepatocellular carcinoma: Role of and crosstalk among WNT/ß-catenin, Sonic Hedgehog, Notch and Dickkopf-1..
Can J Gastroenterol Hepatol. 29(4), 209-17.
(2015). Are statins 'IDEAL' for non-alcoholic fatty liver disease?.
Curr Med Res Opin. 30(2), 229-31.
(2014). Current and future challenges in the surgical treatment of hepatocellular carcinoma: a review..
Int Surg. 99(6), 779-86.
(2014). Hepatocellular carcinoma..
Wien Med Wochenschr. 164(21-22), 450-5.
(2014). Role of microRNA in the diagnosis and therapy of hepatocellular carcinoma: a new frontier..
Microrna. 3(3), 137-43.
(2014). The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference..
J Viral Hepat. 20 Suppl 2, 1-20.
(2013). Long-term outcomes of patients with primary biliary cirrhosis and hepatocellular carcinoma..
Clin Gastroenterol Hepatol. 10(2), 182-5.
(2012). [Multidisciplinary management of hepatocellular carcinoma in cirrhotic patients]..
Rev Med Brux. 33(4), 229-36.
(2012). Relationship between baseline hepatic status and outcome, and effect of sorafenib on liver function: SHARP trial subanalyses..
J Hepatol. 56(5), 1080-8.
(2012). Surgical treatment for large hepatocellular carcinoma: does size matter?.
ANZ J Surg. 82(7-8), 510-7.
(2012). HCC influence on patient survival after liver transplantation for HDV cirrhosis..
Hepatogastroenterology. 58(110-111), 1654-8.
(2011). Long-term experience with liver transplantation for hepatocellular carcinoma..
J Gastroenterol. 46(2), 249-56.
(2011). The potential adverse role of leptin resistance in nonalcoholic fatty liver disease: a hypothesis based on critical review of the literature..
J Clin Gastroenterol. 45(1), 50-4.
(2011).
(2011). Impact of a living donor liver transplant program for hepatocellular carcinoma to the running local deceased donor liver transplant program..
Dig Dis Sci. 55(3), 872-3.
(2010). Safety of transarterial chemoembolization plus sorafenib combination treatment in unresectable hepatocellular carcinoma..
Scand J Gastroenterol. 45(4), 511-2.
(2010).